These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9850479)

  • 21. The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study.
    Bommer C; Heesemann E; Sagalova V; Manne-Goehler J; Atun R; Bärnighausen T; Vollmer S
    Lancet Diabetes Endocrinol; 2017 Jun; 5(6):423-430. PubMed ID: 28456416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Projection of Diabetes Population Size and Associated Economic Burden through 2030 in Iran: Evidence from Micro-Simulation Markov Model and Bayesian Meta-Analysis.
    Javanbakht M; Mashayekhi A; Baradaran HR; Haghdoost A; Afshin A
    PLoS One; 2015; 10(7):e0132505. PubMed ID: 26200913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The economic impact of sight loss and blindness in the UK adult population.
    Pezzullo L; Streatfeild J; Simkiss P; Shickle D
    BMC Health Serv Res; 2018 Jan; 18(1):63. PubMed ID: 29382329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The social and economic cost of diabetes mellitus].
    López Bastida J; Serrano Aguilar P; Duque González B
    Aten Primaria; 2002 Feb; 29(3):145-50. PubMed ID: 11879600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The economic burden of type 2 diabetes mellitus in rural southwest China.
    Le C; Lin L; Jun D; Jianhui H; Keying Z; Wenlong C; Ying S; Tao W
    Int J Cardiol; 2013 May; 165(2):273-7. PubMed ID: 21908062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Costs of diabetes in Texas, 1992.
    Warner DC; McCandless RR; De Nino LA; Cornell JE; Pugh JA; Marsh GM
    Diabetes Care; 1996 Dec; 19(12):1416-9. PubMed ID: 8941474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Economic cost and burden of dengue during epidemics and non-epidemic years in Taiwan.
    Luh DL; Liu CC; Luo YR; Chen SC
    J Infect Public Health; 2018; 11(2):215-223. PubMed ID: 28757293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Projecting the future diabetes population size and related costs for the U.S.
    Huang ES; Basu A; O'Grady M; Capretta JC
    Diabetes Care; 2009 Dec; 32(12):2225-9. PubMed ID: 19940225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Direct and indirect diabetes costs in the world].
    Logminiene Z; Norkus A; Valius L
    Medicina (Kaunas); 2004; 40(1):16-26. PubMed ID: 14764977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Global collaboration on road traffic injury prevention.
    Peden M
    Int J Inj Contr Saf Promot; 2005 Jun; 12(2):85-91. PubMed ID: 16156532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The economic burden of physical inactivity: a global analysis of major non-communicable diseases.
    Ding D; Lawson KD; Kolbe-Alexander TL; Finkelstein EA; Katzmarzyk PT; van Mechelen W; Pratt M;
    Lancet; 2016 Sep; 388(10051):1311-24. PubMed ID: 27475266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetes: the cost of illness in Sweden.
    Henriksson F; Jönsson B
    J Intern Med; 1998 Dec; 244(6):461-8. PubMed ID: 9893099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economics of diabetes mellitus.
    Krein SL; Funnell MM; Piette JD
    Nurs Clin North Am; 2006 Dec; 41(4):499-511, v-vi. PubMed ID: 17059971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. World Health Organization Estimates of the Global and Regional Disease Burden of 22 Foodborne Bacterial, Protozoal, and Viral Diseases, 2010: A Data Synthesis.
    Kirk MD; Pires SM; Black RE; Caipo M; Crump JA; Devleesschauwer B; Döpfer D; Fazil A; Fischer-Walker CL; Hald T; Hall AJ; Keddy KH; Lake RJ; Lanata CF; Torgerson PR; Havelaar AH; Angulo FJ
    PLoS Med; 2015 Dec; 12(12):e1001921. PubMed ID: 26633831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incremental treatment expenditure of diabetes in the United States.
    Balu S
    Manag Care Interface; 2007 Apr; 20(4):20-7. PubMed ID: 17474327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes, a global public health challenge with a high epidemiological and economic burden on health systems in Latin America.
    Arredondo A; Azar A; Recamán AL
    Glob Public Health; 2018 Jul; 13(7):780-787. PubMed ID: 28447537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Technology and the issue of cost/benefit in diabetes.
    Giannini C; Mohn A; Chiarelli F
    Diabetes Metab Res Rev; 2009 Sep; 25 Suppl 1():S34-44. PubMed ID: 19662616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The health-related social costs of alcohol in Belgium.
    Verhaeghe N; Lievens D; Annemans L; Vander Laenen F; Putman K
    BMC Public Health; 2017 Dec; 17(1):958. PubMed ID: 29246218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of diabetes mellitus on healthcare costs in Italy.
    Giorda CB; Manicardi V; Diago Cabezudo J
    Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):709-19. PubMed ID: 22098288
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.